Cargando…
Prostate cancer screening: and yet it moves!
The debate of prostate cancer (PCa) screening has been shaped over decades. There is a plethora of articles in the literature supporting as well as declining prostate-specific antigen (PSA) screening. Does screening decrease PCa mortality? With the long-term results of the European Randomized Study...
Autores principales: | Kwiatkowski, Maciej, Randazzo, Marco, Kluth, Luis, Manka, Lukas, Huber, Andreas, Recker, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430944/ https://www.ncbi.nlm.nih.gov/pubmed/25532573 http://dx.doi.org/10.4103/1008-682X.143310 |
Ejemplares similares
-
To screen or not to screen: the prostate cancer dilemma
por: Stone, Nelson N, et al.
Publicado: (2015) -
The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2020) -
Appraising the European randomized study of screening for prostate cancer: what do the results mean?
por: Ilic, Dragan
Publicado: (2015) -
External beam radiotherapy for localized prostate cancer
por: Yilmaz, Hasan, et al.
Publicado: (2015) -
Testosterone replacement therapy and the risk of prostate cancer
por: Warburton, Daniel, et al.
Publicado: (2015)